![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/02 | |
A61K 39/00 | |||
A61K 39/39 | |||
A61K 47/50 | |||
A61K 47/64 |
(11) | Number of the document | 2519265 |
(13) | Kind of document | T |
(96) | European patent application number | 10818096.9 |
Date of filing the European patent application | 2010-12-30 | |
(97) | Date of publication of the European application | 2012-11-07 |
(45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2010/003484 |
Date | 2010-12-30 |
(87) | Number | WO 2011/080595 |
Date | 2011-07-07 |
(30) | Number | Date | Country code |
291262 P | 2009-12-30 | US |
(72) |
COSTANTINO, Paolo, IT
SERINO, Laura, IT
ROMANO, Maria Rosaria, IT
TONTINI, Marta, IT
BERTI, Francesco, IT
MICOLI, Francesca, IT
KABANOVA, Anna, IT
|
(73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
(54) | POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS |
POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS |